World Trade Center responders have increased levels of mutations that escalate blood cancer risk

Scientists from Vanderbilt-Ingram Cancer Center (VICC) collaborated with researchers from New York to determine that 9/11 first responders to the World Trade Center have increased levels of mutations that escalate their risk for blood cancers or cardiovascular disease, according to a study published March 7 in Nature Medicine.

Related Keywords

New York ,United States ,Memorial Sloan Kettering Cancer Center ,New York University ,Shannon Stockton ,Alexander Silver ,Michael Savona ,Travis Spaulding ,Emily Henderson ,Cosmin Adi Bejan ,Vanderbilt Ingram Cancer Center ,Rutgers Cancer Institute Of New Jersey ,Sylvester Comprehensive Cancer Center ,Edwardp Evans Foundation ,V Foundation For Cancer Research ,York University School Of Medicine ,Genoptix ,Biff Ruttenberg Foundation ,Savona Lab ,World Trade Center ,International Association Of Firefighters ,National Institutes Of Health ,Albert Einstein College Of Medicine ,Leukemia Lymphoma Society ,George Rawlings Directorship In Hematology Research ,Dana Farber Cancer Center ,Adventure Alle Fund ,Montefiore Medical Center ,Synthetic Derivative ,International Association ,George Rawlings Directorship ,Hematology Research ,Cellular Therapy ,Stem Cell Transplantation ,Albert Einstein College ,Fire Department ,New York Bureau ,Health Services ,Rutgers Cancer Institute ,New Jersey ,Weill Cornell Medicine ,New York University School ,Dana Farber Cancer ,National Institutes ,Cancer Research ,Biomedical Informatics ,Blood ,Blood Cancer ,Dancer ,Cardiovascular Disease ,Clinical Testing ,Na ,Hematology ,Hematopoiesis ,Leukemia ,Lymphoma ,Medicine ,Research ,